Ftse Mib
34.241,42
-0,39%
DAX
18.488,91
-0,60%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,00%
Bitcoin
63.776,91
-1,66%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Chiron (MM) (CHIR) Chiron (MM) (CHIR) Notizie

CHIR

Chiron (CHIR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CHIR
DataOraFonteTitoloSimboloCompagnia
17/10/200522:01Business WireChiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customers; First Shipments Mark Beginning of 2005-2006 FLUVIRIN SuppNASDAQ:CHIRChiron (MM)
17/10/200522:01Business WireChiron to Hold Conference Call on Flu Vaccines on Monday, October 17; Company Will Discuss the Return of FLUVIRIN(R) Influenza VNASDAQ:CHIRChiron (MM)
11/10/200514:00Business WireChiron to Release Earnings on Tuesday, October 25, 2005; Conference Call / Audio Webcast to FollowNASDAQ:CHIRChiron (MM)
21/09/200522:24Business WireChiron to Present At UBS Global Life Sciences ConferenceNASDAQ:CHIRChiron (MM)
05/09/200522:02Business WireChiron Responds to Novartis OfferNASDAQ:CHIRChiron (MM)
01/09/200509:08Business WireChiron Confirms Receipt of Novartis OfferNASDAQ:CHIRChiron (MM)
31/08/200515:00Business WireChiron Announces Favorable Results of FDA Inspection of FLUVIRIN(R) Influenza Virus Vaccine Manufacturing FacilityNASDAQ:CHIRChiron (MM)
20/07/200514:00Business WireChiron Will Not Supply BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets for the 2005-2006 Influenza Season; Company is WNASDAQ:CHIRChiron (MM)
15/07/200514:00Business WireFDA Requests Additional Data on PULMINIQ(TM) (Cyclosporine, USP) Inhalation Solution; Agency Action Letter States that PULMINIQNASDAQ:CHIRChiron (MM)
15/07/200514:00Business WireFDA On-Site Inspection of Chiron's FLUVIRIN(R) Influenza Virus Vaccine Facility Underway; Full cGMP Inspection Process ExpectedNASDAQ:CHIRChiron (MM)
15/07/200514:00Business WireChiron Reduces Supply Expectations for BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. MarketsNASDAQ:CHIRChiron (MM)
13/07/200514:00Business WireChiron to Release Earnings on Wednesday, July 27, 2005; Conference Call/Audio Webcast to FollowNASDAQ:CHIRChiron (MM)
15/06/200515:00Business WireChiron Revises Production Range for FLUVIRIN Vaccine and Updates Financial Guidance; Delays in Reaching Full-Scale Production ExNASDAQ:CHIRChiron (MM)
14/06/200514:01Business WireChiron Compound Enters Clinical Trials Through the Global Alliance for TB Drug Development; Phase I Studies to Begin for First TNASDAQ:CHIRChiron (MM)
09/06/200514:00Business WireChiron Foundation Awards Grants to Bay Area Community Organizations Committed to Workforce Development; Grants Support TrainingNASDAQ:CHIRChiron (MM)
08/06/200514:00Business WireChiron to Present at Goldman Sachs Global Healthcare ConferenceNASDAQ:CHIRChiron (MM)
07/06/200503:13Business WirePULMINIQ -- Cyclosporine, USP -- Inhalation Solution Receives Majority Support on Safety and Tie Vote on Efficacy from FDA AdvisNASDAQ:CHIRChiron (MM)
02/06/200514:01Business WireChiron and the Multiple Myeloma Research Consortium Announce Initiation of Phase I Clinical Trial for CHIR-258NASDAQ:CHIRChiron (MM)
11/05/200514:01Business WireChiron to Present at Banc of America Healthcare ConferenceNASDAQ:CHIRChiron (MM)
10/05/200514:30Business WireChiron's Chief Scientific Officer Elected to National Academy of Sciences; Academy Recognizes Rino Rappuoli's Vaccines WorkNASDAQ:CHIRChiron (MM)
04/05/200522:00Business WireChiron to Present at Baird 2005 Growth Stock ConferenceNASDAQ:CHIRChiron (MM)
03/05/200514:00Business WireChiron Foundation Awards Four Grants to Aid New Approaches in Medical Research and Health PolicyNASDAQ:CHIRChiron (MM)
02/02/200522:05PR Newswire (US)U.S. Biologics License Application Submitted for PROCLEIX(R) West Nile Virus Assay for Blood ScreeningNASDAQ:CHIRChiron (MM)
17/11/200417:00PR Newswire (US)Northern California US District Court Rules on Chiron Temporary Restraining Order Sought Against SourceCFNASDAQ:CHIRChiron (MM)
15/10/200403:31PR Newswire (US)Shareholder Class Action Filed Against Chiron Corporation by The Law Firm of Schiffrin & Barroway, LLPNASDAQ:CHIRChiron (MM)
14/10/200418:30PR Newswire (US)Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Chiron CorporationNASDAQ:CHIRChiron (MM)
10/09/200423:00PR Newswire (US)Chiron Announces Settlement with Roche in HIV Patent DisputeNASDAQ:CHIRChiron (MM)
10/09/200403:24PR Newswire (US)Chiron Appoints Richard Wills to Board of DirectorsNASDAQ:CHIRChiron (MM)
01/09/200415:30PR Newswire (US)Testing With Procleix(R) West Nile Virus Assay Initiated on Procleix(R) TIGRIS(R) System Under INDNASDAQ:CHIRChiron (MM)
31/08/200415:30PR Newswire (US)Chiron Acquires Prion Solutions Inc.NASDAQ:CHIRChiron (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CHIR

La tua Cronologia

NASDAQ
PTIX
Protagenic Therapeutics
BIT
UB5FW0
Unicredit Bank
LSE
IEBC
Ishrc Euro
NYSE
XIN
Xinyuan Real Estate
NASDAQ
OXLCP
Oxford Lane Capital
BIT
HEDJ
WisdomTree Europe Equity...
BIT
UB6DC3
Unicredit Bank
BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network